Subsequently, we hypothesized that Slit3 regulated HCC tumor growth through manipulation of the GSK3β/β-catenin pathway which is commonly associated with the development of HCC and other liver diseases [36]. This evidence concerns the gene SLIT3 and hepatocellular carcinoma.